読み込み中
NASDAQHealthcareMedical - Diagnostics & Research
最新データ
$2.04
+$0.02 · +0.99%
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
前日終値
$2.04
+$0.02 · +0.99%
日中の時刻はETです。市場データは遅延する場合があります。
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
日中レンジ
現在 $2.04
52週レンジ
現在 $2.04
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
売り
バリュエーション
25
割高
センチメント
57
まちまち
リスク
74
高リスク
モメンタム
27
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
日中レンジ
現在 $2.04
52週レンジ
現在 $2.04
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 8.1万 USD | 7.7万 USD | 30.6万 USD | 26.8万 USD | 8.2万 USD |
| 売上原価 | 16.4万 USD | 8.2万 USD | 21万 USD | 19.3万 USD | 3.7万 USD |
| 粗利益 | −8.3万 USD | −5000 USD | 9.6万 USD | 7.5万 USD | 4.5万 USD |
| 研究開発 | 1317.1万 USD | 1473万 USD | 1522.5万 USD | 1424.4万 USD | 1101.9万 USD |
| 販売・一般管理 | 2325万 USD | 2190万 USD | 2469.2万 USD | 3148.3万 USD | 2442.1万 USD |
| 営業費用 | 3642.1万 USD | 3663万 USD | 3991.7万 USD | 4572.7万 USD | 3544万 USD |
| 受取利息 | 458.5万 USD | 274.7万 USD | 164万 USD | 45.6万 USD | 14.5万 USD |
| 支払利息 | 9000 USD | 2.8万 USD | 5.5万 USD | 6.1万 USD | 74.6万 USD |
| 減価償却費と償却費 | 94万 USD | 83.3万 USD | 90万 USD | 75.6万 USD | 65.9万 USD |
| 営業利益 | −3650.4万 USD | −3663.5万 USD | −3982.1万 USD | −4565.2万 USD | −3539.5万 USD |
| 純利益 | −3192.8万 USD | −3289.8万 USD | −3624.2万 USD | −4418.6万 USD | −3500.9万 USD |
会社概要が更新されました 2026年10月10日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
平均目標
$6.00
上昇余地（194.12%）この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI188.05万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Extended Market ETFVXF80.6万0.00%954億 USD0.05%$235+0.80%
iShares Micro-Cap ETFIWC20.94万0.02%13.17億 USD0.60%$183+0.11%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM10万0.09%1.17億 USD0.73%$15.9402+0.25%
Avantis U.S. Small Cap Equity ETFAVSC1.09万—30.82億 USD0.25%$69.98+0.03%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR1.03万0.00%455.91億 USD0.17%$84.44+0.44%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMAvantis U.S. Small Cap Equity ETFAVSCU.S. Core Equity 1 Portfolio ETF Class SharesDCORAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
